Xie YD - Search Results

1

Novel selective cannabinoid CB(1) receptor antagonist MJ08 with potent in vivo bioactivity and inverse agonistic effects.

Chen W, Xu C, Liu HY, Long L, Zhang W, Zheng ZB, Xie YD, Wang LL, Li S. Chen W, et al. Among authors: xie yd. Acta Pharmacol Sin. 2011 Sep;32(9):1148-58. doi: 10.1038/aps.2011.80. Epub 2011 Aug 15. Acta Pharmacol Sin. 2011. PMID: 21841814 Free PMC article.

2

Novel selective antagonist of the cannabinoid CB1 receptor, MJ15, with prominent anti-obesity effect in rodent models.

Chen W, Tang H, Liu H, Long L, Gong Z, Zheng J, Chi M, Xie Y, Zheng Z, Li S, Wang L. Chen W, et al. Eur J Pharmacol. 2010 Jul 10;637(1-3):178-85. doi: 10.1016/j.ejphar.2010.03.040. Epub 2010 Apr 7. Eur J Pharmacol. 2010. PMID: 20380831

3

(S)-3-(4-(2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)-2-(piperazin-1-yl) propanoic acid compounds: synthesis and biological evaluation of dual PPARalpha/gamma agonists.

Zhou X, Chen W, Xu C, Fan S, Xie Y, Zhong W, Wang L, Li S. Zhou X, et al. Bioorg Med Chem Lett. 2010 Apr 15;20(8):2605-8. doi: 10.1016/j.bmcl.2010.02.071. Epub 2010 Mar 1. Bioorg Med Chem Lett. 2010. PMID: 20299214

4

Hepatic Steatosis Analysis in Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Artificial Intelligence.

Wang XX, Song YY, Jin R, Wang ZL, Li XH, Yang Q, Teng X, Liu FF, Wu N, Xie YD, Rao HY, Liu F. Wang XX, et al. Among authors: xie yd. Diagnostics (Basel). 2024 Dec 23;14(24):2889. doi: 10.3390/diagnostics14242889. Diagnostics (Basel). 2024. PMID: 39767250 Free PMC article.

5

[Transrectal ultrasonography of intravesical prostatic protrusion and the detection rate of clinically significant prostate cancer].

Dai Y, Xie YD, Xu CL, Yang B. Dai Y, et al. Among authors: xie yd. Zhonghua Nan Ke Xue. 2024 Apr;30(4):326-330. Zhonghua Nan Ke Xue. 2024. PMID: 39210419 Chinese.

6

Evolution of the Active Phase of Pt/Sn-Al₂O₃ Catalysts During Acidic Impregnation and Their Use in Propane Dehydrogenation.

Yang H, Wang X, Xie YD, Lu AH. Yang H, et al. Among authors: xie yd. ACS Appl Mater Interfaces. 2024 Sep 11;16(36):47773-47783. doi: 10.1021/acsami.4c11358. Epub 2024 Aug 28. ACS Appl Mater Interfaces. 2024. PMID: 39196598

7

An Active and Regenerable Nanometric High-Entropy Catalyst for Efficient Propane Dehydrogenation.

Zhou SZ, Li WC, He B, Xie YD, Wang H, Liu X, Chen L, Wei J, Lu AH. Zhou SZ, et al. Among authors: xie yd. Angew Chem Int Ed Engl. 2024 Oct 21;63(43):e202410835. doi: 10.1002/anie.202410835. Epub 2024 Sep 12. Angew Chem Int Ed Engl. 2024. PMID: 39044707

8

Superprotonic conductivity of ketoenamine covalent-organic frameworks grafted by imidazole-based units.

Zhang T, Xia Y, Xie YD, Du HJ, Shi ZQ, Hu HL, Zhang H, Guo ZC, Li G. Zhang T, et al. Among authors: xie yd. J Colloid Interface Sci. 2024 Jul;665:554-563. doi: 10.1016/j.jcis.2024.03.164. Epub 2024 Mar 26. J Colloid Interface Sci. 2024. PMID: 38552572

9

Efficacy and safety of agomelatine in the treatment of patients with depressive disorder: A meta-analysis.

Guo YH, Zhou L, Cui ZA, Wang J, Zhang L, Xu T, Xie YD, Chen H. Guo YH, et al. Among authors: xie yd. Medicine (Baltimore). 2023 Nov 10;102(45):e35871. doi: 10.1097/MD.0000000000035871. Medicine (Baltimore). 2023. PMID: 37960759 Free PMC article.

10

Biomimetic hypoxia-triggered RNAi nanomedicine for synergistically mediating chemo/radiotherapy of glioblastoma.

Wang Z, Tang XL, Zhao MJ, Zhang YD, Xiao Y, Liu YY, Qian CF, Xie YD, Liu Y, Zou YJ, Yang K, Liu HY. Wang Z, et al. Among authors: xie yd. J Nanobiotechnology. 2023 Jul 5;21(1):210. doi: 10.1186/s12951-023-01960-w. J Nanobiotechnology. 2023. PMID: 37408007 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters